¿Afecta el estrés laboral a la salud?

Se trata de determinar cómo las condiciones de trabajo y la incertidumbre laboral van a tener un impacto significativo sobre la salud de los trabajadores

El estado de salud y las condiciones de trabajo de la población ocupada en España

Objetivos: Resulta obvio que el estado de salud está determinado por múltiples factores socioeconómicos o hábitos de vida, distintos a la asistencia sanitaria. Este trabajo se centra en los relativos al mercado laboral, tratando de cuantificar el efecto del estrés y aspectos relacionados con las condiciones de trabajo sobre el estado de salud autopercibido o el indicador de salud mental GHQ-12. Material y métodos: Las fuentes de información seleccionadas serán la Encuesta Nacional de Salud (2011/12) y la Encuesta Nacional de Condiciones de Trabajo 2011. Ésta recopila información detallada sobre el puesto de trabajo, factores psicosociales, horario y conciliación laboral y familiar de los ocupados. Como ventaja adicional, valora si los problemas de salud declarados se han producido o agravado por el trabajo que realizan. Los problemas de endogeneidad que afectan a tales relaciones se han tratado mediante modelos probit multivariante y/o propensity score matching. Resultados: Los resultados preliminares con la ENS confirman que una jornada irregular o partida y tener responsabilidad sobre otros trabajadores aumentan la probabilidad de soportar un nivel de estrés elevado. A su vez, éste incrementa la probabilidad de padecer depresión, úlcera de estómago, problemas cervicales y lumbares. Estos problemas de salud y un elevado nivel de estrés aumentan la probabilidad de declarar un estado de salud regular, malo o muy malo. Conclusiones: La inversión en políticas de salud laboral resultará beneficiosa para reducir los efectos de condiciones laborales adversas sobre la salud de los trabajadores, los beneficios empresariales y la sociedad.Universidad de Málaga. Campus de Excelencia Internacional Andalucí

Telemedicine, Psychology and Diabetes: Evaluation of results and cost analysis

The Psychosocial Aspects of Diabetes (PSAD) Study Group is an official Study Group of the European Association for the Study of Diabetes (EASD).AIMS: Evidences of benefits of telemedicine in T1DM patients on continuous subcutaneous insulin infusion (CSII) treatment are limited. Aims: 1) to analyse the differences in clinical and psychological variables between subjects with T1DM on CSII treatment who were included in a Telecare (TC) program, and subjects with T1DM on CSII treatment who received Conventional care (CC); 2) Perform a cost analysis of the use of telemedicine in DM1 patients treated with CSII (TC versus CC). METHODS and PARTICIPANTS: Cross-over randomized clinical trial with duration of 18 months. 51 patients signed informed consent. Participants were randomly assigned to receive TC program or CC during 6 months, and after a 3 months wash-out period, patients changed to CC or to TC respectively. TC program included monthly visits using an Internet platform. CC comprised face-to-face visits every three months. Sociodemographic, clinical and psychological data was measured at the beginning and at the end of TC and CC. The direct and indirect costs were also measured. T Student was performed to assess differences between first and last visits in both groups (TC / CC). RESULTS: Patients with telemedicine at the end of treatment, have fewer hyperglycemia / week, less distress and greater adherence. Considering both direct and indirect costs, the cost per treatment (TC / CC) is similar. CONCLUSIONS: Telemedicine has significant implications for clinical and psychological variables and has the same cost (total) than the conventional treatment. Therefore, it can be a useful alternative for treatment of DM1 patients with CSII. However, studies with a larger sample size are needed.Universidad de Málaga. Campus de Excelencia Internacional Andalucía Tech

HIV-1 promonocytic and lymphoid cell lines: an in vitro model of in vivo mitochondrial and apoptotic lesion.

To characterize mitochondrial/apoptotic parameters in chronically human immunodeficiency virus (HIV-1)-infected promonocytic and lymphoid cells which could be further used as therapeutic targets to test pro-mitochondrial or anti-apoptotic strategies as in vitro cell platforms to deal with HIV-infection. Mitochondrial/apoptotic parameters of U1 promonocytic and ACH2 lymphoid cell lines were compared to those of their uninfected U937 and CEM counterparts. Mitochondrial DNA (mtDNA) was quantified by rt-PCR while mitochondrial complex IV (CIV) function was measured by spectrophotometry. Mitochondrial-nuclear encoded subunits II-IV of cytochrome-c-oxidase (COXII-COXIV), respectively, as well as mitochondrial apoptotic events [voltage-dependent-anion-channel-1(VDAC-1)-content and caspase-9 levels] were quantified by western blot, with mitochondrial mass being assessed by spectrophotometry (citrate synthase) and flow cytometry (mitotracker green assay). Mitochondrial membrane potential (JC1-assay) and advanced apoptotic/necrotic events (AnexinV/propidium iodide) were measured by flow cytometry. Significant mtDNA depletion spanning 57.67% (P < 0.01) was found in the U1 promonocytic cells further reflected by a significant 77.43% decrease of mitochondrial CIV activity (P < 0.01). These changes were not significant for the ACH2 lymphoid cell line. COXII and COXIV subunits as well as VDAC-1 and caspase-9 content were sharply decreased in both chronic HIV-1-infected promonocytic and lymphoid cell lines (<0.005 in most cases). In addition, U1 and ACH2 cells showed a trend (moderate in case of ACH2), albeit not significant, to lower levels of depolarized mitochondrial membranes. The present in vitro lymphoid and especially promonocytic HIV model show marked mitochondrial lesion but apoptotic resistance phenotype that has been only partially demonstrated in patients. This model may provide a platform for the characterization of HIV-chronicity, to test novel therapeutic options or to study HIV reservoirs

LVGPy: Diseño, desarrollo y puesta en marcha de un “Laboratorio Virtual de Geomatemática en lenguaje Python”

Se describen los objetivos, metodología y resultados del Proyecto de Innovación con Nº de proyecto 211, Convocatoria 2017/2017. El proyecto fue desarrollado por profesores de las Facultades de Biología y Geología

CONTRIVE-UCM

El proyecto CONTRIVE-UCM se basa en crear una herramienta digital en línea que permita transformar la gestión de la calidad e innovación dentro de la Facultad de Enfermería, Fisioterapia y Podología (FEFyP) hacia un modelo virtual, mediante la captación de ideas por parte de todo el personal del centro involucrando tanto docentes como estudiantes, con el fin de democratizar y mejorar la transparencia de los programas formativos, los procesos de calidad, a través de la participación activa en el uso de la herramienta digital como experiencia innovadora

Estudos Artísticos

Arte em transe. De um modo especializado, dentro do projeto criadores sobre outras obras, a revista Croma interessa-se pela implicação, a intervenção, e a valorização. Nesta sétima edição reuniram-se 17 artigos que tomam como ponto comum a abordagem de obras que exigem diferentes formas de participação. As propostas artísticas não funcionam sem a interação das pessoas. O seu suporte vital, funcional, o seu sentido, estas dimensões, materiais e imateriais, convergem para as pessoas vivas que com elas atuam. Sobre estes artigos podemos promover diferentes abordagens. Mas interessará estudar o que motivou os temas apresentados. Podem detetar-se regularidades dentro dos espaços de implicação que privilegiamos na revista Croma. Quais são estas regularidades? Encontramos alguns núcleos problematizadores comuns: o género, a inclusão, a migração, o corpo, a identidade.info:eu-repo/semantics/publishedVersio

Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy:Study protocol of a cluster randomized clinical trial (Multi-PAP project)

This study was funded by the Fondo de Investigaciones Sanitarias ISCIII (Grant Numbers PI15/00276, PI15/00572, PI15/00996), REDISSEC (Project Numbers RD12/0001/0012, RD16/0001/0005), and the European Regional Development Fund ("A way to build Europe").Background: Multimorbidity is associated with negative effects both on people's health and on healthcare systems. A key problem linked to multimorbidity is polypharmacy, which in turn is associated with increased risk of partly preventable adverse effects, including mortality. The Ariadne principles describe a model of care based on a thorough assessment of diseases, treatments (and potential interactions), clinical status, context and preferences of patients with multimorbidity, with the aim of prioritizing and sharing realistic treatment goals that guide an individualized management. The aim of this study is to evaluate the effectiveness of a complex intervention that implements the Ariadne principles in a population of young-old patients with multimorbidity and polypharmacy. The intervention seeks to improve the appropriateness of prescribing in primary care (PC), as measured by the medication appropriateness index (MAI) score at 6 and 12months, as compared with usual care. Methods/Design: Design:pragmatic cluster randomized clinical trial. Unit of randomization: family physician (FP). Unit of analysis: patient. Scope: PC health centres in three autonomous communities: Aragon, Madrid, and Andalusia (Spain). Population: patients aged 65-74years with multimorbidity (≥3 chronic diseases) and polypharmacy (≥5 drugs prescribed in ≥3months). Sample size: n=400 (200 per study arm). Intervention: complex intervention based on the implementation of the Ariadne principles with two components: (1) FP training and (2) FP-patient interview. Outcomes: MAI score, health services use, quality of life (Euroqol 5D-5L), pharmacotherapy and adherence to treatment (Morisky-Green, Haynes-Sackett), and clinical and socio-demographic variables. Statistical analysis: primary outcome is the difference in MAI score between T0 and T1 and corresponding 95% confidence interval. Adjustment for confounding factors will be performed by multilevel analysis. All analyses will be carried out in accordance with the intention-to-treat principle. Discussion: It is essential to provide evidence concerning interventions on PC patients with polypharmacy and multimorbidity, conducted in the context of routine clinical practice, and involving young-old patients with significant potential for preventing negative health outcomes. Trial registration: Clinicaltrials.gov, NCT02866799Publisher PDFPeer reviewe